<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Four <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell lines; NALM-20, established at the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0001909'>leukemia</z:hpo> and NALM-21, -22 and -23 established at the relapse of the disease were found to be t(9;22)-positive <z:hpo ids='HP_0001909'>leukemia</z:hpo> lines having the biphenotypic feature of B cell and myeloid cell characteristics </plain></SENT>
<SENT sid="1" pm="."><plain>In addition, a polyclonal Epstein-Barr virus-transformed <z:mpath ids='MPATH_458'>normal</z:mpath> B cell line, B250, was established from the peripheral blood at the <z:hpo ids='HP_0003674'>onset</z:hpo> of the disease </plain></SENT>
</text></document>